Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Camp4 Therapeutics (CAMP) Profit After Tax (2023 - 2025)

Historic Profit After Tax for Camp4 Therapeutics (CAMP) over the last 3 years, with Q3 2025 value amounting to -$15.1 million.

  • Camp4 Therapeutics' Profit After Tax fell 1197.72% to -$15.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$53.4 million, marking a year-over-year decrease of 369.89%. This contributed to the annual value of -$51.8 million for FY2024, which is 509.02% down from last year.
  • Latest data reveals that Camp4 Therapeutics reported Profit After Tax of -$15.1 million as of Q3 2025, which was down 1197.72% from -$12.6 million recorded in Q2 2025.
  • In the past 5 years, Camp4 Therapeutics' Profit After Tax ranged from a high of -$11.7 million in Q3 2023 and a low of -$15.1 million during Q3 2025
  • For the 3-year period, Camp4 Therapeutics' Profit After Tax averaged around -$13.0 million, with its median value being -$12.6 million (2025).
  • As far as peak fluctuations go, Camp4 Therapeutics' Profit After Tax crashed by 1528.73% in 2024, and later rose by 15.26% in 2025.
  • Camp4 Therapeutics' Profit After Tax (Quarter) stood at -$13.0 million in 2023, then fell by 2.29% to -$13.3 million in 2024, then dropped by 13.63% to -$15.1 million in 2025.
  • Its Profit After Tax stands at -$15.1 million for Q3 2025, versus -$12.6 million for Q2 2025 and -$12.4 million for Q1 2025.